The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease

被引：41

作者：

Beck, M ^{[1
]}

机构：

[1] Univ Mainz, Childrens Hosp, D-6500 Mainz, Germany

来源：

ACTA PAEDIATRICA | 2006年 / 95卷

关键词：

Fabry disease; MSSI;

D O I：

10.1080/08035320600618825

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Fabry disease is a rare lysosomal storage disorder caused by the deficient activity of the lysosomal enzyme a-galactosidase A. The resultant storage of undegraded glycolipids leads to the progressive development of potentially life-threatening manifestations affecting multiple organ systems in the body. This paper describes the development of the Mainz Severity Score Index (MSSI), a scoring system for patients with Fabry disease. Conclusion: The MSSI score has been proven to be representative in patients with 'classic' Fabry disease and may be useful for monitoring clinical improvement in patients receiving enzyme replacement therapy.

引用

页码：43 / 46

页数：4

共 50 条

[31] Genital Lymphedema Score: Genital Lymphedema Severity Scoring System Based on Subjective Symptoms
Yamamoto, Takumi
Yamamoto, Nana
Furuya, Megumi
Hayashi, Akitatsu
Koshima, Isao
ANNALS OF PLASTIC SURGERY, 2016, 77 (01) : 119 - 121
[32] DEVELOPMENT AND VALIDATION OF AN ENDOSCOPIC SCORING SYSTEM FOR ACHALASIA (THE CAMERON'S SCORE)
Peller, Matthew
Carlson, Dustin
Keswani, Rajesh N.
Schauer, Jacob
Pandolfino, John E.
GASTROENTEROLOGY, 2022, 162 (07) : S553 - S554
[33] Development of a disease severity scoring system for patients with Pompe disease.
Giannini, E. H.
Berger, K.
van der Ploeg, A.
Case, L.
Dandrea, C.
Kishnani, P.
Marsden, D.
MOLECULAR GENETICS AND METABOLISM, 2008, 93 (03) : 250 - 250
[34] Development of a disease severity scoring system for type I Gaucher disease
Zimran, Ari
Cappellini, Maria
Cox, Timothy
Gianini, Edward
Grabowski, Gregory A.
Hwu, Wuh-Liang
Mankin, Henry
Martins, Anna Maria
Sawyer, Carolyn
vom Dahl, Stephan
Weinreb, Neal
Yeh, Michael
MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S45 - S45
[35] DEVELOPMENT OF A DISEASE SEVERITY SCORING SYSTEM FOR TYPE 1 GAUCHER DISEASE
Cappellini, M. D.
Cox, T.
Giannini, E. H.
Grabowski, G. A.
Hwu, W. L.
Mankin, H.
Martins, A. M.
Sawyer, C.
Dahl, S. Vom
Weinreb, N.
Yeh, M.
Zimran, A.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 19 - 19
[36] DEVELOPMENT OF A DISEASE SEVERITY SCORING SYSTEM FOR TYPE 1 GAUCHER DISEASE
Zimran, A.
Cappellini, M. D.
Cox, T.
Giannini, E. H.
Grabowski, G. A.
Hwu, W. L.
Mankin, H.
Martins, A. M.
Sawyers, C.
vom Dahl, S.
Weinreb, N.
Yeh, M.
CLINICAL THERAPEUTICS, 2008, 30 : S95 - S95
[37] Development and validation of a new disease severity index: the Inflammatory Bowel Disease Index (IBDEX)
Alrubaiy, Laith
Dodds, Phedra
Hutchings, Hayley Anne
Russell, Ian Trevor
Watkins, Alan
Williams, John Gordon
FRONTLINE GASTROENTEROLOGY, 2015, 6 (03) : 161 - 168
[38] Development and validation of a symptom-based severity score for haemorrhoidal disease: the Sodergren score
Pucher, P. H.
Qurashi, M.
Howell, A. -M.
Faiz, O.
Ziprin, P.
Darzi, A.
Sodergren, M. H.
COLORECTAL DISEASE, 2015, 17 (07) : 612 - 618
[39] Italian patients in FOS - the Fabry Outcome Survey: assessment of the clinical picture and effect of agalsidase alfa tested using the Mainz Severity Score Index
Parini, R.
Rigoldi, M.
Santus, F.
De Lorenzo, P.
Sersale, G.
Furlan, F.
Borsini, W.
Burlina, A.
Burlina, A. B.
Concolina, D.
Di Vito, R.
Ravaglia, R.
Ricci, R.
Strisciuglio, P.
ACTA PAEDIATRICA, 2007, 96 : 103 - 103
[40] A simplified critical illness severity scoring system (CISSS): Development and internal validation
Fortis, Spyridon
O'Shea, Amy M. J.
Beck, Brice F.
Nair, Rajeshwari
Goto, Michihiko
Schmidt, Gregory A.
Kaboli, Peter J.
Perencevich, Eli N.
Reisinger, Heather Schacht
Sarrazin, Mary Vaughan
JOURNAL OF CRITICAL CARE, 2021, 61 : 21 - 28

← 1 2 3 4 5 →